スポンサーリンク
Dept. Obst. and Gynec., Tokai Univ. Sch. Med. | 論文
- 119. Analysis of Human Sperm Motility with Computer Assisted Measurement: Correlation of Results with in vitro Fertilization
- 351. High-dose Combination Chemotherapy with Autologous Bone Marrow Transplantation in Gynecological Malignancies
- 52. Electron Microscopy of Human Ova Inseminated in vitro
- 388. Therapeutic Triales of in utero Fertilization (IUF) and in vitro Fertilization (IVF)
- 41. Follow up Study of Cervical Dysplasia
- 18. (Abstract is not Available)
- 86 Results of in vitro fertilization-embryo transfer on outpatient bases : comparison of three protocoles for time of embryo transfer.
- 85 The prognostic evaluation in detection of appearance of gestational sac and fetal heart movement following success of in vitro fertilization-embryo transfer.
- 95 Analysis of follow up laparoscopies (LS) 231 times in 91 patients with ovarian cancer after initial treatmet.
- 19 Immunohistochemical and serological studies on detectoin of SCCAA in precancer and/or cancer of uterine cervix.
- 471 Effect of Immunotherapy in Infertile Couples of in vitro fertilization-embryo tubal replacement (IVF-ETR) failure.
- 108 Follow-up laparoscopies (LS) in patients with ovarian cancer : Application to individualization of additional chemotherapy after initial treatment
- 16. High-dose Chemotherapy with Autologous Bone Marrow Transplantation in Malignant Ovarian Tumors
- 424. Application of Immunocytochemistry to the Cytologic Study of Ascitic Fluid in Ovarian Cancer
- 423. Laparoscopy for Evaluation of Response to Chemotherapy in Ovarian Cancer
- 335. Serological Study by Using a New Agglutination Test on Sera of Cervical Cancer Patients
- 37. Evolution of Renal Open Biopsy in Toxemia of Pregnancy
- 406. Changes of Fetal Heart Variability after Epidural Analgesia Using Two-catheter Technique in Labor
- 408 Second (Third) cytoreductive surgery in recurrent cases of malignant ovarian tumor.
- 403 High-dose chemotherapy (HDC) with autologous bone marrow transplantation (ABMT) in patients with Stage III/IV ovarian cancer.